Mechanistically, they reported that MDSCs induce the EMT in breast cancer cells by activating the PI3K/AKT/mTOR signaling pathway and increasing the expression of matrix metalloproteinases (MMPs), thus increasing the invasion and metastatic potential of breast cancer cells [131]. The gene discussed is MTOR; the disease is breast carcinoma.